Global Prostate Cancer Drugs Market Research Report 2017

August 2017 | 126 pages | ID: GB1D9BE90D8EN
QYResearch

Abstracts

In this report, the global Prostate Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Prostate Cancer Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Prostate Cancer Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• AbbVie
• Astellas Pharma
• Astra Zeneca
• Johnson & Johnson
• Sanofi
• GlaxoSmithKline
• Merck Group
• Novartis
• Amgen
• Bayer HealthCare
• Ferring Pharmaceutical
• Janssen Pharmaceuticals
• Endo Pharmaceuticals
• BMS
• Takeda Pharmaceuticals
• Northwest Biotherapeutics
• Teva Pharmaceutical
• Boehringer Ingelheim
• Foresee Pharmaceuticals
• Tokai Pharmaceuticals
• Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Prostate Cancer Drugs for each application, including

• Clinics
• Hospitals
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Prostate Cancer Drugs Market Research Report 2017

1 PROSTATE CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type (Product Category)
  1.2.1 Global Prostate Cancer Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Prostate Cancer Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Hormonal Therapy
  1.2.4 Chemotherapy
  1.2.5 Immunotherapy
  1.2.6 Targeted Therapy
1.3 Global Prostate Cancer Drugs Segment by Application
  1.3.1 Prostate Cancer Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Clinics
  1.3.3 Hospitals
  1.3.4 Other
1.4 Global Prostate Cancer Drugs Market by Region (2012-2022)
  1.4.1 Global Prostate Cancer Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Prostate Cancer Drugs (2012-2022)
  1.5.1 Global Prostate Cancer Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Prostate Cancer Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL PROSTATE CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Prostate Cancer Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Prostate Cancer Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Prostate Cancer Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Prostate Cancer Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
  2.5.1 Prostate Cancer Drugs Market Concentration Rate
  2.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PROSTATE CANCER DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Prostate Cancer Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Prostate Cancer Drugs Production and Market Share by Region (2012-2017)
3.3 Global Prostate Cancer Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL PROSTATE CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Prostate Cancer Drugs Consumption by Region (2012-2017)
4.2 North America Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Prostate Cancer Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL PROSTATE CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Prostate Cancer Drugs Production and Market Share by Type (2012-2017)
5.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Prostate Cancer Drugs Price by Type (2012-2017)
5.4 Global Prostate Cancer Drugs Production Growth by Type (2012-2017)

6 GLOBAL PROSTATE CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PROSTATE CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 AbbVie
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 AbbVie Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Astellas Pharma
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Astellas Pharma Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Astra Zeneca
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Astra Zeneca Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Johnson & Johnson
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Johnson & Johnson Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Sanofi Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 GlaxoSmithKline Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Merck Group
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Merck Group Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Novartis
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Novartis Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Amgen
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Amgen Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Bayer HealthCare
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Prostate Cancer Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Bayer HealthCare Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Ferring Pharmaceutical
7.12 Janssen Pharmaceuticals
7.13 Endo Pharmaceuticals
7.14 BMS
7.15 Takeda Pharmaceuticals
7.16 Northwest Biotherapeutics
7.17 Teva Pharmaceutical
7.18 Boehringer Ingelheim
7.19 Foresee Pharmaceuticals
7.20 Tokai Pharmaceuticals
7.21 Spectrum Pharmaceuticals

8 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Prostate Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostate Cancer Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prostate Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PROSTATE CANCER DRUGS MARKET FORECAST (2017-2022)

12.1 Global Prostate Cancer Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Prostate Cancer Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Prostate Cancer Drugs Price and Trend Forecast (2017-2022)
12.2 Global Prostate Cancer Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Prostate Cancer Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Prostate Cancer Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Figure Global Prostate Cancer Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Prostate Cancer Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Hormonal Therapy
Table Major Manufacturers of Hormonal Therapy
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Immunotherapy
Table Major Manufacturers of Immunotherapy
Figure Product Picture of Targeted Therapy
Table Major Manufacturers of Targeted Therapy
Figure Global Prostate Cancer Drugs Consumption (K Pcs) by Applications (2012-2022)
Figure Global Prostate Cancer Drugs Consumption Market Share by Applications in 2016
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Prostate Cancer Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Prostate Cancer Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Prostate Cancer Drugs Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Prostate Cancer Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Prostate Cancer Drugs Major Players Product Production (K Pcs) (2012-2017)
Table Global Prostate Cancer Drugs Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Prostate Cancer Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Prostate Cancer Drugs Production Share by Manufacturers
Figure 2017 Prostate Cancer Drugs Production Share by Manufacturers
Figure Global Prostate Cancer Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Prostate Cancer Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2017 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table Global Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Drugs Product Category
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Prostate Cancer Drugs Capacity (K Pcs) by Region (2012-2017)
Figure Global Prostate Cancer Drugs Capacity Market Share by Region (2012-2017)
Figure Global Prostate Cancer Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Drugs Capacity Market Share by Region
Table Global Prostate Cancer Drugs Production by Region (2012-2017)
Figure Global Prostate Cancer Drugs Production (K Pcs) by Region (2012-2017)
Figure Global Prostate Cancer Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Drugs Production Market Share by Region
Table Global Prostate Cancer Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Prostate Cancer Drugs Revenue Market Share by Region (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Prostate Cancer Drugs Revenue Market Share by Region
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Market by Region (2012-2017)
Table Global Prostate Cancer Drugs Consumption Market Share by Region (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Prostate Cancer Drugs Consumption (K Pcs) Market Share by Region
Table North America Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Prostate Cancer Drugs Production (K Pcs) by Type (2012-2017)
Table Global Prostate Cancer Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Prostate Cancer Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Price (USD/Pcs) by Type (2012-2017)
Figure Global Prostate Cancer Drugs Production Growth by Type (2012-2017)
Table Global Prostate Cancer Drugs Consumption (K Pcs) by Application (2012-2017)
Table Global Prostate Cancer Drugs Consumption Market Share by Application (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Market Share by Application in 2016
Table Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure AbbVie Prostate Cancer Drugs Production Market Share (2012-2017)
Figure AbbVie Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astra Zeneca Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Sanofi Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Sanofi Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Merck Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Group Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Group Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Merck Group Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Merck Group Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Novartis Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Novartis Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Amgen Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Amgen Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Production Growth Rate (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Production Market Share (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Prostate Cancer Drugs Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Prostate Cancer Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Prostate Cancer Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Prostate Cancer Drugs Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Drugs Production (K Pcs) Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Price Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source